Edition:
United States

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

606.75INR
28 Apr 2017
Change (% chg)

Rs-0.30 (-0.05%)
Prev Close
Rs607.05
Open
Rs610.00
Day's High
Rs623.35
Day's Low
Rs604.10
Volume
3,566,219
Avg. Vol
2,100,823
52-wk High
Rs895.00
52-wk Low
Rs604.10

Latest Key Developments (Source: Significant Developments)

Aurobindo Pharma says US FDA issued form 483 with 6 observations for unit-III
Wednesday, 19 Apr 2017 05:11am EDT 

April 19 (Reuters) - Aurobindo Pharma Ltd :Clarifies on news item "US FDA issues 5-6 'largely procedural' observations to Aurobindo Pharma's Unit-III".Says have been issued a form 483 with 6 observations.Observations are all on procedural improvements.Says none of observations related to data integrity.  Full Article

Aurobindo Pharma gets FDA nod for generic drug to treat HIV-1 infection
Thursday, 30 Mar 2017 12:58am EDT 

Aurobindo Pharma Ltd : Says Aurobindo Pharma receives USFDA approval for generic Epzicom tablets . Says product being launched immediately .Says tablets intented to treat HIV-1 infection.  Full Article

Aurobindo Pharma gets USFDA nod for Meropenem injection
Tuesday, 28 Mar 2017 12:10am EDT 

Aurobindo Pharma Ltd : Says co gets USFDA approval for Meropenem injection . Meropenem injection is a generic equivalent of Astrazeneca Pharma's Merrem injection .Drug indicated to treat complicated skin & skin structure infections, complicated intra-abdominal infections & bacterial meningitis.  Full Article

Aurobindo Pharma gets FDA nod for generic version of Reckitt Benckiser’s Mucinex DM tablets
Monday, 20 Mar 2017 08:27am EDT 

Aurobindo Pharma Ltd : Says Aurobindo Pharma receives USFDA approval for guaifenesin and dextromethorphan hydrobromide . Says the product will be launched in Q1FY18. . guaifenesin and dextromethorphan hydrobromide extended-release tablets are AB rated generic equivalent of Reckitt Benckiser’S Mucinex DM tablets .Guaifenesin and dextromethorphan hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions.  Full Article

Aurobindo Pharma says co became aware of complaint from numerous states filed in Connecticut
Friday, 16 Dec 2016 02:46am EST 

Aurobindo Pharma Ltd : says co became aware of complaint from numerous states filed in Connecticut . says received subpoena in mar 2016 requesting non-product specific information . says have not received any further requests for information or subpoenas after March 2016 subpoena .says sales of Glyburide by our US subsidiary is not material.  Full Article

Aurobindo Pharma unit Arrow Generiques to buy select assets in France from Teva
Friday, 25 Nov 2016 07:21am EST 

Aurobindo Pharma Ltd : Aurobindo Pharma Ltd says Arrow Generiques to acquire select assets in France from Teva . Aurobindo Pharma Ltd says Arrow Generiques will integrate the products with existing commercial operations in France . Aurobindo Pharma Ltd says Arrow Generiques and Teva intend to ensure continuity of the supply of the products to the market. .Aurobindo Pharma - Arrow Generiques to buy right, title and interest in products calcium and calcium vitamin d3, including use of the orocal trademark..  Full Article

Aurobindo Pharma gets USFDA tentative approval for Dolutegravir
Thursday, 22 Sep 2016 03:12am EDT 

Aurobindo Pharma Ltd :Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the PEPFAR market.  Full Article

Aurobindo Pharma receives USFDA approval for Linezolid injection
Monday, 8 Aug 2016 12:33am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives USFDA approval for Linezolid injection . Product is expected to be launched by Q2 FY 2016-17 .  Full Article

Aurobindo Pharma gets USFDA approval for rosuvastatin calcium tablets
Wednesday, 20 Jul 2016 12:19am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives usfda approval for rosuvastatin calcium tablets .  Full Article

Aurobindo Pharma gets USFDA approval for hydromorphone hydrochloride tablets
Tuesday, 17 May 2016 01:50am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives usfda approval for hydromorphone hydrochloride tablets .  Full Article

More From Around the Web

BRIEF-Aurobindo Pharma says US FDA issued form 483 with 6 observations for unit-III

* Clarifies on news item "US FDA issues 5-6 'largely procedural' observations to Aurobindo Pharma's Unit-III"